Ontology highlight
ABSTRACT: Context
Hypoglycemia, one of the major factors limiting optimal glycemic control in insulin-treated patients with diabetes, elicits a brain response to restore normoglycemia by activating counterregulation. Animal data indicate that local release of norepinephrine (NE) in the hypothalamus is important for triggering hypoglycemia-induced counterregulatory (CR) hormonal responses.Objective
To examine the potential role of brain noradrenergic (NA) activation in humans during hypoglycemia.Design
A hyperinsulinemic-hypoglycemic clamp was performed in conjunction with positron emission tomographic imaging.Participants
Nine lean healthy volunteers were studied during the hyperinsulinemic-hypoglycemic clamp.Design
Participants received intravenous injections of (S,S)-[11C]O-methylreboxetine ([11C]MRB), a highly selective NE transporter (NET) ligand, at baseline and during hypoglycemia.Results
Hypoglycemia increased plasma epinephrine, glucagon, cortisol, and growth hormone and decreased [11C]MRB binding potential (BPND) by 24% ± 12% in the raphe nucleus (P < 0.01). In contrast, changes in [11C]MRB BPND in the hypothalamus positively correlated with increments in epinephrine and glucagon levels and negatively correlated with glucose infusion rate (all P < 0.05). Furthermore, in rat hypothalamus studies, hypoglycemia induced NET translocation from the cytosol to the plasma membrane.Conclusions
Insulin-induced hypoglycemia initiated a complex brain NA response in humans. Raphe nuclei, a region involved in regulating autonomic output, motor activity, and hunger, had increased NA activity, whereas the hypothalamus showed a NET-binding pattern that was associated with the individual's CR response magnitude. These findings suggest that NA output most likely is important for modulating brain responses to hypoglycemia in humans.
SUBMITTER: Belfort-DeAguiar R
PROVIDER: S-EPMC6456998 | biostudies-literature | 2018 Jun
REPOSITORIES: biostudies-literature
The Journal of clinical endocrinology and metabolism 20180601 6
<h4>Context</h4>Hypoglycemia, one of the major factors limiting optimal glycemic control in insulin-treated patients with diabetes, elicits a brain response to restore normoglycemia by activating counterregulation. Animal data indicate that local release of norepinephrine (NE) in the hypothalamus is important for triggering hypoglycemia-induced counterregulatory (CR) hormonal responses.<h4>Objective</h4>To examine the potential role of brain noradrenergic (NA) activation in humans during hypogly ...[more]